Skip to main content
logo
Biosergen AB (publ) (STO:BIOSGN)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.340
-0.030 (-2.19%)
Sep 4, 2026, 1:19 PM CET

Biosergen AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
----0.46-0.28-0.21
Operating Income
-32.34-38.04-19.2-27.27-34.13-40.89
Net Income
-32.32-38.01-19.2-27.04-34.05-41.18
Earnings Per Share
-13.77-16.19-8.17-53.00-109.00-146.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
3.2315.3750.611.8829.3421.67
Net Cash Growth
-90.28%-69.64%2587.84%-93.58%35.44%-
Net Cash Per Share
1.386.5421.543.6993.9377.02
Cash & Investments
3.2315.3750.611.8829.3421.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-31.46-36.81-10.18-32.6-29.44-45.3
Free Cash Flow
-31.46-36.81-10.18-32.6-29.44-45.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-1.181.182.20--